F Sigaux
Impact in
- Oncology top 1%
- Viral-associated cancers and disorders
- Hematology top 1%
- Acute Myeloid Leukemia Research
Papers in
- Hematology 26
- Acute Myeloid Leukemia Research 19
- Chronic Myeloid Leukemia Treatments 8
- Genetics 18
- Chronic Lymphocytic Leukemia Research 17
- Co-authors
- L DegosJean SoulierMartine RaphaëlÉric OksenhendlerL GrolletP BabinetJP ClauvelDominique Cazals‐Hatem
- Journals
- Blood (13 papers)British Journal of Haematology (5 papers)Leukemia (3 papers)The Journal of Experimental Medicine (3 papers)The Journal of Immunology (3 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
F Sigaux
67 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 2.2k
- Hematology 890
- Pathology and Forensic Medicine 953
- Immunology 876
- Genetics 408
Countries citing papers authored by F Sigaux
This map shows the geographic impact of F Sigaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Sigaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Sigaux more than expected).
Fields of papers citing papers by F Sigaux
This network shows the impact of papers produced by F Sigaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Sigaux. The network helps show where F Sigaux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F Sigaux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 22 | |
| 2 | 2008 | 43 | |
| 3 | 2005 | 40 | |
| 4 | 2003 | 12 | |
| 5 | 2002 | 86 | |
| 6 | 2000 | 17 | |
| 7 | 2000 | 17 | |
| 8 | 1999 | 56 | |
| 9 | 1999 | 1 | |
| 10 | 1997 | 78 | |
| 11 | 1996 | 11 | |
| 12 | Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases. | 1995 | 24 |
| 13 | 1994 | 70 | |
| 14 | Chronic myelocytic leukaemia with unusual (27 years) complete remission terminating in acute undifferentiated leukaemia: a clinical and karyotypic study. | 1991 | 4 |
| 15 | 1990 | 43 | |
| 16 | 1990 | 103 | |
| 17 | 1989 | 21 | |
| 18 | 1989 | 43 | |
| 19 | 1988 | 13 | |
| 20 | 1987 | 88 |
About F Sigaux
F Sigaux is a scholar working on Hematology, Genetics, Immunology, Oncology and Pathology and Forensic Medicine, having authored 69 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Chronic Lymphocytic Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (16 papers), Immune Cell Function and Interaction (12 papers), CAR-T cell therapy research (9 papers), Immunodeficiency and Autoimmune Disorders (9 papers), T-cell and B-cell Immunology (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Oncology (2.2k citations), Hematology (890 citations), Pathology and Forensic Medicine (953 citations), Immunology (876 citations) and Genetics (408 citations). F Sigaux has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include L Degos, Jean Soulier, Martine Raphaël, Éric Oksenhendler, L Grollet, P Babinet, JP Clauvel, Dominique Cazals‐Hatem, P. Cacoub and Georges Flandrin. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.